Skip to content

Sensititre GPN3F

by Trek Diagnostic Systems, Inc.

Ref GPN3F

Sensititre GPN3F is an in vitro diagnostic device (EU IVDD general IVD; FDA Class II; EMDN category gram positive susceptibility testing - automated) made by Trek Diagnostic Systems, Inc., registered in EUDAMED on 27 Aug 2026 (Basic UDI-DI B-05032384474370), cleared under FDA 510(k) K060783 on 16 May 2006 and listed in FDA GUDID since 11 Apr 2025 (UDI-DI 05032384474370), active as of 24 Oct 2026.

Active European Union and United States. Also listed in GUDID (US).

CE IVDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 24 Oct 2026

Documents

None, self-declared

Class I: no certifier involved

510(k) K060783

FDA submission, from GUDID

Trust

Unverified

Source EUDAMED, GUDID, synced 24 Oct 2026.

Regulatory status

as of registry sync 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-05032384474370 Basic UDI-DI 05032384474370UDI-DIDate27 Aug 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number05032384474370 UDI-DI Date11 Apr 2025ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE GUDID from GUDID Substantially Equivalent · Traditional NumberK060783 Date16 May 2006DecidedStatusActive

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 24 Oct 2026, as the labeller entered it.

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI B-05032384474370 registered 27 Aug 2026 Active
  • FDA 510(k) K060783 decided 16 May 2006 Active
  • FDA GUDID UDI-DI 05032384474370 listed 11 Apr 2025 Listed

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Timeline

3 dated events

  1. Cleared FDA 510(k) K060783
  2. Listed FDA GUDID 05032384474370
  3. Registered EUDAMED B-05032384474370

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · GUDID

Trade name
Sensititre GPN3F EUDAMED
Sensititre GUDID
Generic name
Multiple antibacterial susceptibility testing kit IVD
Model / reference
GPN3F
Primary DI / UDI-DI
05032384474370
Basic UDI-DI
B-05032384474370
510(k) Number
FDA product code
JWY, LRG
EMDN code
W0104080108 Gram positive susceptibility testing - automated
GMDN term
Multiple antibacterial susceptibility testing kit IVD
Device class
Class IVD General EUDAMED
Class II GUDID
Regulation number
866.1640
EU registration type
Legacy device (under a directive)
EU market of registration
Netherlands
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IVD General
GUDID
Class II

Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under GRAM POSITIVE SUSCEPTIBILITY TESTING - AUTOMATED.

Other devices from Trek Diagnostic Systems, Inc.

  • STP8F

    Class II
  • CMC1NJNF

    Class II
  • Sensititre Vizion

    Class II
  • Sensititre CMC3VGNF

    Class II

See all devices from Trek Diagnostic Systems, Inc. →

Properties

  • Single use
  • Contains animal tissues or cells
  • Reagent
  • Professional testing
  • Prescription use
  • Lot / batch number
  • Expiration date
  • Manufacturing date
Other properties (17, all answered No)